High Tower Advisors, LLC Amgen Inc Transaction History

High Tower Advisors, LLC

$68.3 Billion
Q3 2024

A detailed history of High Tower Advisors, LLC transactions in Amgen Inc stock. As of the latest transaction made, High Tower Advisors, LLC holds 703,607 shares of AMGN stock, worth $185 Million. This represents 0.33% of its overall portfolio holdings.

Number of Shares

703,607

Previous 633,744 11.02%

Holding current value

$185 Million

Previous $198 Million 14.49%

% of portfolio

0.33%

Previous 0.31%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$309.38 - $337.38 $21.6 Million - $23.6 Million	69,863 Added 11.02%	703,607 $227 Million
Q2 2024 Aug 13, 2024	BUY	$262.75 - $319.31 $5.38 Million - $6.54 Million	20,484 Added 3.34%	633,744 $198 Million
Q1 2024 May 06, 2024	SELL	$268.87 - $324.56 $20.1 Million - $24.2 Million	-74,617 Reduced 10.85%	613,260 $174 Million
Q4 2023 Feb 12, 2024	BUY	$255.7 - $288.46 $6.61 Million - $7.45 Million	25,840 Added 3.9%	687,877 $198 Million
Q3 2023 Nov 08, 2023	SELL	$218.65 - $271.46 $39,138 - $48,591	-179 Reduced 0.03%	662,037 $178 Million
Q2 2023 Aug 14, 2023	BUY	$214.27 - $253.37 $5.97 Million - $7.06 Million	27,880 Added 4.4%	662,216 $147 Million
Q1 2023 May 11, 2023	BUY	$225.79 - $275.2 $12.4 Million - $15.1 Million	54,770 Added 9.45%	634,336 $153 Million
Q4 2022 Feb 08, 2023	BUY	$229.03 - $291.01 $1.6 Million - $2.03 Million	6,986 Added 1.22%	579,566 $152 Million
Q3 2022 Nov 09, 2022	BUY	$224.46 - $253.15 $3.65 Million - $4.12 Million	16,277 Added 2.93%	572,580 $129 Million
Q2 2022 Aug 10, 2022	BUY	$230.71 - $256.74 $176,954 - $196,919	767 Added 0.14%	556,303 $135 Million
Q1 2022 May 12, 2022	BUY	$219.27 - $242.57 $7.38 Million - $8.16 Million	33,648 Added 6.45%	555,536 $134 Million
Q4 2021 Feb 10, 2022	BUY	$198.88 - $227.6 $353,012 - $403,990	1,775 Added 0.34%	521,888 $117 Million
Q3 2021 Nov 12, 2021	BUY	$212.27 - $248.7 $7.4 Million - $8.66 Million	34,839 Added 7.18%	520,113 $111 Million
Q2 2021 Aug 06, 2021	BUY	$233.58 - $259.14 $10.7 Million - $11.9 Million	45,869 Added 10.44%	485,274 $118 Million
Q1 2021 May 10, 2021	SELL	$221.91 - $258.6 $828,390 - $965,353	-3,733 Reduced 0.84%	439,405 $109 Million
Q4 2020 Feb 10, 2021	BUY	$216.38 - $257.67 $5.94 Million - $7.07 Million	27,429 Added 6.6%	443,138 $102 Million
Q3 2020 Nov 13, 2020	SELL	$234.65 - $260.95 $227,610 - $253,121	-970 Reduced 0.23%	415,709 $106 Million
Q2 2020 Aug 10, 2020	SELL	$197.81 - $242.74 $438,742 - $538,397	-2,218 Reduced 0.53%	416,679 $98.3 Million
Q1 2020 May 21, 2020	BUY	$182.24 - $241.7 $76.3 Million - $101 Million	418,897 New	418,897 $84.8 Million
Q4 2019 Feb 14, 2020	SELL	$189.21 - $243.2 $83.1 Million - $107 Million	-439,325 Closed	0 $0
Q3 2019 Nov 12, 2019	SELL	$174.11 - $208.62 $285,366 - $341,928	-1,639 Reduced 0.37%	439,325 $85.1 Million
Q2 2019 Aug 13, 2019	BUY	$166.7 - $195.41 $1.72 Million - $2.02 Million	10,340 Added 2.4%	440,964 $81.3 Million
Q1 2019 May 15, 2019	SELL	$180.87 - $203.88 $8.21 Million - $9.25 Million	-45,385 Reduced 9.53%	430,624 $81.8 Million
Q4 2018 Feb 14, 2019	SELL	$178.4 - $208.25 $1.74 Million - $2.03 Million	-9,768 Reduced 2.01%	476,009 $92.8 Million
Q3 2018 Nov 09, 2018	BUY	$185.29 - $208.89 $2.51 Million - $2.83 Million	13,557 Added 2.87%	485,777 $101 Million
Q2 2018 Aug 14, 2018	BUY	$166.05 - $186.51 $2.82 Million - $3.17 Million	16,970 Added 3.73%	472,220 $87.2 Million
Q1 2018 May 15, 2018	BUY	$169.43 - $198.0 $13.5 Million - $15.8 Million	79,906 Added 21.29%	455,250 $77.6 Million
Q4 2017 Feb 14, 2018	SELL	$168.79 - $188.59 $2.62 Million - $2.93 Million	-15,514 Reduced 3.97%	375,344 $65.2 Million
Q3 2017 Nov 14, 2017	BUY	$167.29 - $191.0 $5.54 Million - $6.32 Million	33,105 Added 9.25%	390,858 $72.9 Million
Q2 2017 Aug 14, 2017	BUY	N/A	357,753	357,753 $61.6 Million

Others Institutions Holding AMGN

# of Institutions

3,125

Shares Held

409M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $141B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of High Tower Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on High Tower Advisors, LLC with notifications on news.

Account

High Tower Advisors, LLC Amgen Inc Transaction History